About this trial
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.
Eligibility criteria
Qualifiers
Adult patients (18 years or older)
Surgical procedure requiring urgent, primary median laparotomy, which are classified as "Class III/Contaminated" or "Class IV/Dirty-Infected" regarding the CDC classification.
Vascular surgery
Colon and rectum
Disqualifiers
Pregnancy
Breast feeding
Patients < 18 years old or patients who are still in the growth phase
Contaminated and infected areas
Trial design
Treatments tested in this trial
- Prophylactic mesh
Treatment groups
Sponsors and collaborators
Aesculap AG
Lead sponsor
B.Braun Surgical SA
Collaborator